Literature DB >> 3731068

Monoclonal antibodies to an epithelial ovarian adenocarcinoma: distinctive reactivity with xenografts of the original tumor and a cultured cell line.

R Baumal, J Law, R N Buick, H Kahn, H Yeger, K Sheldon, T Colgan, A Marks.   

Abstract

Four monoclonal antibodies (mAb) (8C, 10B, M2A, and M2D) were produced against the human epithelial ovarian adenocarcinoma cell line, HEY. The affinity constants of binding of the mAb to cultured HEY cells were 8 X 10(8) M-1 (M2D) and 10(9) M-1 (8C and 10B). mAb 8C reacted with a major glycoprotein of Mr 90,000 on the surface of HEY cells. The four mAb differed from previously reported mAb to epithelial ovarian adenocarcinomas on the basis of their reactivity with cultured ovarian adenocarcinoma cell lines using a cell-binding radioimmunoassay, and their staining of cryostat sections of various human normal and tumor tissues using an immunoperoxidase reaction. All four mAb reacted with s.c. tumors derived by injecting cultured HEY cells into thymectomized CBA/CJ mice. However, only two of the four mAb (8C and 10B) also reacted with s.c. tumors of the original HEY xenograft from which the cultured cell line was derived. In addition, mAb 8C and 10B reacted by immunoperoxidase staining with 2 and 4 different cases, respectively, of 11 epithelial ovarian adenocarcinomas examined. Cultured HEY cells were adapted to grow i.p. in BALB/c-nu/nu mice and the i.p. tumors retained their reactivity with the monoclonal antibodies. These tumor-bearing mice offer a useful model system for studying the potential of mAb, especially 8C and 10B, for the diagnosis and treatment of patients with peritoneal extension of epithelial ovarian adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731068

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Inhibition of RNase L and RNA-dependent protein kinase (PKR) by sunitinib impairs antiviral innate immunity.

Authors:  Babal Kant Jha; Irina Polyakova; Patricia Kessler; Beihua Dong; Benjamin Dickerman; Ganes C Sen; Robert H Silverman
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  Phospholipid scramblase 1 potentiates the antiviral activity of interferon.

Authors:  Beihua Dong; Quansheng Zhou; Ji Zhao; Aimin Zhou; Ronald N Harty; Santanu Bose; Amiya Banerjee; Roger Slee; Jeanna Guenther; Bryan R G Williams; Therese Wiedmer; Peter J Sims; Robert H Silverman
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  Binding parameters of monoclonal antibodies reacting with ovarian carcinoma ascites cells.

Authors:  M J Mattes; K O Lloyd; J L Lewis
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells.

Authors:  G B Mills; C May; M Hill; S Campbell; P Shaw; A Marks
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

5.  Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells.

Authors:  Q Cai; L Yan; Y Xu
Journal:  Oncogene       Date:  2014-08-18       Impact factor: 9.867

6.  Homologous 2',5'-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity.

Authors:  Rong Zhang; Babal K Jha; Kristen M Ogden; Beihua Dong; Ling Zhao; Ruth Elliott; John T Patton; Robert H Silverman; Susan R Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

7.  Murine AKAP7 has a 2',5'-phosphodiesterase domain that can complement an inactive murine coronavirus ns2 gene.

Authors:  Elona Gusho; Rong Zhang; Babal K Jha; Joshua M Thornbrough; Beihua Dong; Christina Gaughan; Ruth Elliott; Susan R Weiss; Robert H Silverman
Journal:  MBio       Date:  2014-07-01       Impact factor: 7.867

8.  RNase L restricts the mobility of engineered retrotransposons in cultured human cells.

Authors:  Ao Zhang; Beihua Dong; Aurélien J Doucet; John B Moldovan; John V Moran; Robert H Silverman
Journal:  Nucleic Acids Res       Date:  2013-12-25       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.